← The Wire
EUDANasdaq
EUDA Health Holdings Ltd
Services-Health Services · D8 · CIK 1847846
Provides non-invasive healthcare solutions and property management services across Asia
$52M
Market cap
$17.31
Last close
-10.3%
1D
-8.9%
5D
19K
Volume
Price$17.31-71.4%· 1Y
Volume
Aug 4L $5.26 · H $77.80Aug 3
Revenue & earnings
RevenueNet incomeLoss
Fundamentals & quality
Trailing fundamentals · via Polygon & SECRev growth YoY
70.0%
Trailing 12 months
Gross margin
43.9%
Gross profit / revenue
Net margin
-40.7%
Net income / revenue
ROE
—
Return on equity
ROIC
—
Return on invested capital
FCF yield
-4.8%
Free cash flow / mkt cap
P/E
—
Price / earnings
P/S
7.6
Price / sales
EV/EBITDA
—
Valuation multiple
Debt / equity
—
Leverage
Piotroski F
4/9
Fundamental strength
Altman Z
—
Distress model
Similar companies
Comparable business profile · signals at a glance
Filings archive
Newest first · each with a one-line AI read · showing 10 of 136Jul 28, 20266-K6-KEUDA Health Holdings Limited announced on July 28, 2026, that it issued a press release. The press release is filed as Exhibit 99.1 to this report.Jul 22, 2026424B5424B5Jun 11, 2026424B5424B5Euda Health Holdings Limited is suspending its "at-the-market" offering of ordinary shares, which had a maximum aggregate offering price of up to $10.0 million. No shares have been sold under this offering, and the company intends to terminate the agreement.Jun 10, 20266-K6-KEUDA Health Holdings Limited has suspended its at-the-market offering and will terminate the related agreement with Chardan Capital Markets LLC, effective July 22, 2026. No shares have been sold under this offering to date.Jun 1, 20266-K6-KEUDA Health Holdings Limited issued a press release on June 1, 2026, regarding unspecified matters.Jun 1, 20266-K6-KEUDA Health Holdings Limited has regained compliance with Nasdaq's Minimum Market Value of Listed Securities requirement after previously failing to meet it. The company's market value of listed securities has been $35 million or greater for ten consecutive business days from May 13 to May 27, 2026.Apr 28, 20266-K6-KEUDA Health Holdings Limited issued a press release on April 28, 2026, detailing unspecified "Other Events."Apr 28, 202620-F20-FEUDA Health Holdings Limited reported a net loss of $2,767,710 for the fiscal year ended December 31, 2025, an improvement from the $15,391,443 net loss in 2024. The company's independent registered public accounting firm's report contains an explanatory paragraph expressing substantial doubt about its ability to continue as a going concern.Apr 27, 20266-K6-KEUDA Health Holdings Limited received a notice from Nasdaq indicating it failed to meet the Minimum Market Value of Listed Securities (MVLS) requirement. The company has 180 days to regain compliance.Mar 19, 20266-K6-KEUDA Health Holdings Limited will implement a 1-for-20 reverse stock split, effective March 23, 2026, which will reduce its outstanding ordinary shares from approximately 50,307,491 to approximately 2,515,375. The company's ordinary shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market on that date.
Show 50 more ↓
Mar 5, 20266-K6-KEUDA Health Holdings Limited filed an Amended and Restated Memorandum and Articles of Association on February 27, 2026, to allow for the division or combination of its ordinary shares. The company also issued a press release on March 4, 2026.Mar 2, 20266-K6-KEUDA Health Holdings Limited completed an offering of 12,500,000 ordinary shares for $3,750,000 and repurchased a warrant for $125,000.Mar 2, 2026424B5424B5Jan 23, 2026424B5424B5Jan 15, 20266-K6-KEUDA Health Holdings Limited issued a press release on January 15, 2026, detailing events for the month of January 2026.Jan 13, 2026424B5424B5Jan 13, 20266-K6-KEUDA Health Holdings Limited amended a warrant agreement on January 13, 2026, reducing the exercise price to $2.00 per share and the forced exercise minimum closing price to $3.00 per share. The company will file a new prospectus supplement to reflect these changes.Jan 13, 20266-K6-KEUDA Health Holdings Limited issued a press release on January 13, 2026.Jan 7, 20266-K6-KEUDA Health Holdings Limited issued a press release on January 7, 2026.Dec 30, 20256-K6-KEUDA Health Holdings Limited issued a press release on December 30, 2025, detailing other events.Dec 29, 20256-K6-KEUDA Health Holdings Limited announced on December 29, 2025, the issuance of a press release.Dec 23, 20256-K6-KEUDA Health Holdings Limited announced on December 23, 2025, that it issued a press release.Dec 22, 20256-K6-KEUDA Health Holdings Limited announced on December 22, 2025, the issuance of a press release. The filing does not contain financial results or other material events.Dec 19, 2025424B5424B5Dec 19, 20256-K6-KEUDA Health Holdings Limited amended a warrant agreement to reduce the exercise price from $6.00 to $4.00 per share and lowered the minimum closing price for a forced exercise from $7.50 to $6.00. The company will file a new prospectus supplement to reflect these changes.Dec 8, 20256-K6-KEUDA Health Holdings Limited issued a press release on December 8, 2025, announcing its financial results.Dec 5, 20256-K6-KEUDA Health Holdings Limited issued a press release on December 5, 2025, announcing other events.Dec 4, 2025424B5424B5Dec 4, 20256-K6-KEUDA Health Holdings Limited entered into a securities purchase agreement to sell a convertible warrant for $100,000, which is immediately exercisable into 2,000,000 ordinary shares at $6.00 per share. The company has rights to require cash exercise or repurchase, and the purchaser may exercise cashless if the company breaches the agreement.Nov 18, 2025424B5424B5Nov 17, 20256-K6-KEUDA Health Holdings Limited has agreed to convert the remaining $162,500 balance of a convertible promissory note into 81,250 ordinary shares. This follows a prior conversion of $837,500 of the note into 569,859 ordinary shares.Oct 28, 20256-K6-KEUDA Health Holdings Limited announced the resignation of an independent director and the appointment of a new independent director, Huang Bo, who has a relationship with a key business partner.Oct 23, 20256-K6-KEUDA Health Holdings Limited issued a press release on October 23, 2025, detailing unspecified events. (2) * The reporting currency is not stated.Oct 20, 20256-K6-KEUDA Health Holdings Limited issued a press release on October 20, 2025, filed as Exhibit 99.1. (2) The reporting currency is not stated. (3) The accounting basis is not stated. (4) The filing is a Form 6-K reporting other events. (5) The registrant has duly caused this report to be signed on its behalf by Alfred Lim, Chief Executive Officer. (6) The report is dated October 20, 2025.Oct 3, 20256-K6-KEUDA Health Holdings Limited amended a letter agreement on October 2, 2025, allowing a convertible note holder the option to convert the remaining $162,500 balance into shares or request cash repayment by November 17, 2025. The company does not intend to issue additional convertible notes.Oct 1, 20256-K6-KEUDA Health Holdings Limited reported a net loss of US$10,230,232 for the six months ended June 30, 2025, compared to a net loss of US$10,131,048 for the six months ended June 30, 2024. The company's total revenue for the six months ended June 30, 2025, was US$1,000,000.Sep 22, 20256-K6-KEUDA Health Holdings Limited has entered into a letter agreement to pause further conversions of a convertible promissory note until December 15, 2025, unless the stock price reaches $2.00 for three consecutive days. The company delivered 41,620 ordinary shares to the purchaser as part of this agreement.Sep 10, 20256-K6-KEUDA Health Holdings Limited issued a press release on September 10, 2025, regarding other events.Sep 4, 20256-K6-KEUDA Health Holdings Limited issued a press release on September 4, 2025, detailing other events.Aug 28, 20256-K6-KEUDA Health Holdings Limited issued a press release on August 28, 2025, regarding other events.Aug 26, 20256-K6-KEUDA Health Holdings Limited announced on August 26, 2025, that it issued a press release. The press release is filed as Exhibit 99.1 to this report.Aug 8, 2025424B5424B5Aug 6, 20256-K6-KJun 24, 2025424B5424B5Jun 24, 20256-K6-KJun 2, 20256-K6-KApr 29, 202520-F20-FApr 24, 20256-K6-KFeb 10, 20256-K6-KDec 16, 20246-K6-KOct 18, 20246-K6-KOct 10, 20246-K6-KSep 9, 20246-K6-KJul 29, 20246-K6-KJul 3, 20246-K6-KJun 26, 20246-K6-KMay 9, 202420-F20-FMay 8, 20246-K6-KMay 7, 20246-K6-KApr 30, 20246-K6-K